You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ruxolitinib

Showing 26 - 50 of 181
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Detroit, Charlotte (Carfilzomib, Ruxolitinib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Detroit, Michigan
  • +1 more
Jan 27, 2023

Discoid Lupus Erythematosus Trial in Rochester (Ruxolitinib)

Enrolling by invitation
  • Discoid Lupus Erythematosus
  • Ruxolitinib
  • Rochester, New York
    UR Medicine Dermatology College Town
May 20, 2022

Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)

Recruiting
  • Myelofibrosis Due to and Following Polycythemia Vera
  • Basking Ridge, New Jersey
  • +6 more
Jan 26, 2023

Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)

Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • Leukemia
  • Ruxolitinib
  • Tampa, Florida
  • +4 more
Nov 11, 2022

Acute Myeloid Leukemia, Myeloid and Monocytic Leukemia, MDS Trial in Minneapolis, Saint Louis, Rochester (Decitabine,

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Minneapolis, Minnesota
  • +2 more
Nov 2, 2022

Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +4 more
  • Ruxolitinib
  • +5 more
  • Utrecht, Netherlands
    Princess Máxima Center for Pediatric Oncology
Feb 16, 2023

Acute Lymphoblastic Leukemia Trial in New York (Ruxolitinib, Dasatinib, Dexamethasone)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Ruxolitinib
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 25, 2022

Necrobiosis Lipoidica Trial in Scottsdale (Ruxolitinib)

Completed
  • Necrobiosis Lipoidica
  • Ruxolitinib
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Mar 17, 2022

Hemophagocytic Lymphohistiocytosis Trial in United States (Ruxolitinib, Dexamethasone, Etoposide)

Recruiting
  • Hemophagocytic Lymphohistiocytosis
  • Ruxolitinib
  • +2 more
  • Phoenix, Arizona
  • +9 more
Jan 9, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, Allogeneic Stem Cell Transplantation Trial in United States

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Ruxolitinib
  • Boston, Massachusetts
  • +5 more
Oct 21, 2022

Myelofibrosis Trial in Coral Gables, Tampa, New York (Imetelstat, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Coral Gables, Florida
  • +2 more
Jul 12, 2022

Advanced Cutaneous Squamous Cell Carcinoma Trial in Atlanta, Chicago, New York (Ruxolitinib)

Recruiting
  • Advanced Cutaneous Squamous Cell Carcinoma
  • Ruxolitinib
  • Atlanta, Georgia
  • +2 more
Jun 28, 2022

Myelofibrosis Trial in United States (Ruxolitinib, Thalidomide)

Active, not recruiting
  • Myelofibrosis
  • Middletown, New Jersey
  • +6 more
Aug 23, 2022

Polycythemia Vera Trial (Ruxolitinib)

Available
  • Polycythemia Vera
  • Ruxolitinib
  • (no location specified)
Mar 7, 2022

Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced), Alopecia Areata Trial run by the National Institute of

Recruiting
  • Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced)
  • Alopecia Areata
  • Ruxolitinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Macrophage Activation Syndrome Trial (Ruxolitinib, methylprednisolone)

Not yet recruiting
  • Macrophage Activation Syndrome
  • (no location specified)
Mar 16, 2022

Lymphoma Trial in United States (Ruxolitinib)

Recruiting
  • Lymphoma
  • Ruxolitinib
  • Miami, Florida
  • +9 more
Oct 5, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +2 more
  • Columbus, Ohio
  • +2 more
Aug 10, 2022

Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease, Solid Organ Transplant Trial in Cincinnati (Ruxolitinib)

Recruiting
  • Acute-graft-versus-host Disease
  • +2 more
  • Ruxolitinib
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Mar 31, 2022

Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Polycythemia Vera
  • Phoenix, Arizona
  • +4 more
Jun 20, 2022

T Cell Leukemia, Adult, Leukemia, Adult T-Cell, T Cell Leukemia, HTLV I Associated Trial run by the NCI (Ruxolitinib,

Completed
  • T Cell Leukemia, Adult
  • +2 more
  • Ruxolitinib
  • ruxolitinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 26, 2022

BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells, Blasts More Than 5 Percent of

Recruiting
  • BCR-JAK2 Fusion Protein Expression
  • +11 more
  • Ruxolitinib
  • Palo Alto, California
  • +3 more
Oct 5, 2022

Kohlmeier Degos Disease With Neurologic Involvement Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

Recruiting
  • Kohlmeier Degos Disease With Neurologic Involvement
  • Ruxolitinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 23, 2023

Myelofibroses Trial in Saint Louis (Pevonedistat, Ruxolitinib, Peripheral blood draw)

Terminated
  • Myelofibroses
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 16, 2021

Myelomonocytic Leukemia Trial in United States (Ruxolitinib)

Completed
Has Results
  • Myelomonocytic Leukemia
  • Ruxolitinib
  • Tampa, Florida
  • +5 more
Sep 9, 2022